Oxysterol binding protein-related protein-5 is related to invasion and poor prognosis in pancreatic cancer

Cancer Science

Volumn 99, Issue 12, 2008, Pages 2387-2394

  Koga, Yoshikatsu ^a   Ishikawa, Shinji ^a   Nakamura, Tadahiko ^a   Masuda, Toshiro ^a   Nagai, Yohei ^a   Takamori, Hiroshi ^a   Hirota, Masahiko ^a   Kanemitsu, Keiichiro ^a   Baba, Yoshifumi ^a,b   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; OXYSTEROL BINDING PROTEIN RELATED PROTEIN 5; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HAMSTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RISK REDUCTION; SURVIVAL RATE; SURVIVAL TIME;

ANIMALS; CELL LINE, TUMOR; CRICETINAE; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PROGNOSIS; RECEPTORS, STEROID; RNA, SMALL INTERFERING; SURVIVAL ANALYSIS;

EID: 57349195604     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00987.x     Document Type: Article

References (45)

1. Pour PM, Egami H, Takiyama Y. Patterns of growth and metastases of induced pancreatic cancer in relation to the prognosis and its clinical implications. Gastroenterology 1991; 100: 529-36.
2. Egami H, Takiyama Y, Cano M, Houser WH, Pour PM. Establishment of hamster pancreatic ductal carcinoma cell line (PC-1) producing blood group-related antigens. Carcinogenesis 1989; 10: 861-9.
3. Egami H, Tomioka T, Tempero M, Kay D, Pour PM. Development of intrapancreatic transplantable model of pancreatic duct adenocarcinoma in Syrian golden hamsters. Am J Pathol 1991; 138: 557-61.
4. Hirota M, Egami H, Corra S et al. Production of scatter factor-like activity by a nitrosamine-induced pancreatic cancer cell line. Carcinogenesis 1993; 14: 259-64.
5. Kurizaki T, Egami H, Hirota M et al. Characterization of cancer cell dissociation factor in a highly invasive pancreatic cancer cell line. Cancer 1995; 75: 1554-61.
6. Ishikawa S, Egami H, Kurizaki T et al. Identification of genes related to invasion and metastasis in pancreatic cancer by cDNA representational difference analysis. J Exp Clin Cancer Res 2003; 22: 299-306.
7. Tan X, Egami H, Kamohara H et al. Involvement of the mitogen-activated protein kinase kinase 2 in the induction of cell dissociation in pancreatic cancer. Int J Oncol 2004; 24: 65-73.
8. Tan X, Egami H, Ishikawa S et al. Relationship between the expression of extracellular signal-regulated kinase 1/2 and the dissociation of pancreatic cancer cells: Involvement of ERK1/2 in the dissociation status of cancer cells. Int J Oncol 2004; 24: 815-20.
9. Tan X, Tamori Y, Egami H et al. Analysis of the invasion-metastasis mechanism in pancreatic cancer: Involvement of tight junction transmembrane protein occludin and MEK/ERK signal transduction pathway in cancer cell dissociation. Oncol Rep 2004; 11: 993-8.
10. Tan X, Egami H, Ishikawa S et al. Relationship between activation of epidermal growth factor receptor and cell dissociation in pancreatic cancer. Int J Oncol 2004; 25: 1303-9.
11. Tan X, Egami H, Ishikawa S et al. Arrangement of expression and distribution of tight junction protein claudin-1 in cell dissociation of pancreatic cancer cells. Int J Oncol 2004; 25: 1567-74.
12. Tan X, Egami H, Ishikawa S et al. Involvement of matrix metalloproteinase-7 in invasion-metastasis through induction of cell dissociation in pancreatic cancer. Int J Oncol 2005; 26: 1283-9.
13. Tan X, Egami H, Ishikawa S, Kurizaki T, Hirota M, Ogawa M. Zonula occludens-1 (ZO-1) redistribution is involved in the regulation of cell dissociation in pancreatic cancer cells. Dig Dis Sci 2005; 50: 1402-9.
14. Lehto M, Laitinen S, Chinetti G et al. The OSBP-related protein family in humans. J Lipid Res 2001; 42: 1203-13.
15. Jaworski CJ, Moreira E, Li A, Lee R, Rodriguez IR. A family of 12 human genes containing oxysterol-binding domains. Genomics 2001; 78: 185-96.
16. Taylor FR, Saucier SE, Shown EP, Parish EJ, Kandutsch AA. Correlation between oxysterol binding to a cytosolic binding protein and potency in the repression of hydroxymethylglutaryl coenzyme A reductase. J Biol Chem 1984; 259: 12 382-7.
17. Taylor FR, Kandutsch AA. Oxysterol binding protein. Chem Phys Lipids 1985; 38: 187-94.
18. Ridgway ND, Dawson PA, Ho YK, Brown MS, Goldstein JL. Translocation of oxysterol binding protein to Golgi apparatus triggered by ligand binding. J Cell Biol 1992; 116: 307-19.
19. Perry RJ, Ridgway ND. Oxysterol-binding protein and vesicle-associated membrane protein-associated protein are required for sterol-dependent activation of the ceramide transport protein. Mol Biol Cell 2006; 17: 2604-16.
20. Suchanek M, Hynynen R, Wohlfahrt G et al. The mammalian oxysterol-binding protein-related proteins (ORPs) bind 25-hydroxycholesterol in an evolutionarily conserved pocket. Biochem J 2007; 405: 473-80.
21. Hynynen R, Laitinen S, Kakela R et al. Overexpression of OSBP-related protein 2 (ORP2) induces changes in cellular cholesterol metabolism and enhances endocytosis. Biochem J 2005; 390: 273-83.
22. Lehto M, Olkkonen VM. The OSBP-related proteins: A novel protein family involved in vesicle transport, cellular lipid metabolism, and cell signalling. Biochim Biophys Acta 2003; 1631: 1-11.
23. Wang PY, Weng J, Anderson RG. OSBP is a cholesterol-regulated scaffolding protein in control of ERK 1/2 activation. Science 2005; 307: 1472-6.
24. Im YJ, Raychaudhuri S, Prinz WA, Hurley JH. Structural mechanism for sterol sensing and transport by OSBP-related proteins. Nature 2005; 437: 154-8.
25. Massey JB. Membrane and protein interactions of oxysterols. Curr Opin Lipidol 2006; 17: 296-301.
26. Fairn GD, Curwin AJ, Stefan CJ, McMaster CR. The oxysterol binding protein Kes1p regulates Golgi apparatus phosphatidylinositol-4-phosphate function. Proc Natl Acad Sci USA 2007; 104: 15 352-7.
27. Lessmann E, Ngo M, Leitges M, Minguet S, Ridgway ND, Huber M. Oxysterol-binding protein-related protein (ORP) 9 is a PDK-2 substrate and regulates Akt phosphorylation. Cell Signal 2007; 19: 384-92.
28. Yan D, Lehto M, Rasilainen L et al. Oxysterol binding protein induces upregulation of SREBP-1c and enhances hepatic lipogenesis. Arterioscler Thromb Vasc Biol 2007; 27: 1108-14.
29. Japan Pancreas Society. Classification of Pancreatic Carcinoma, 2nd English edn. Tokyo: Kanehara & Co., 2003.
30. Dawson PA, Ridgway ND, Slaughter CA, Brown MS, Goldstein JL. cDNA cloning and expression of oxysterol-binding protein, an oligomer with a potential leucine zipper. J Biol Chem 1989; 264: 16 798-803.
31. Levanon D, Hsieh CL, Francke U et al. cDNA cloning of human oxysterol-binding protein and localization of the gene to human chromosome 11 and mouse chromosome 19. Genomics 1990; 7: 65-74.
32. Olkkonen VM, Levine TP. Oxysterol binding proteins: In more than one place at one time? Biochem Cell Biol 2004; 82: 87-98.
33. Lagace TA, Byers DM, Cook HW, Ridgway ND. Altered regulation of cholesterol and cholesteryl ester synthesis in Chinese hamster ovary cells overexpressing the oxysterol-binding protein is dependent on the pleckstrin homology domain. Biochem J 1997; 326: 205-13.
34. Levine TP, Munro S. The pleckstrin homology domain of oxysterol-binding protein recognises a determinant specific to Golgi membranes. Curr Biol 1998; 8: 729-39.
35. Balla A, Tuymetova G, Tsiomenko A, Varnai P, Balla T. A plasma membrane pool of phosphatidylinositol 4-phosphate is generated by phosphatidylinositol 4-kinase type-III alpha: Studies with the PH domains of the oxysterol binding protein and FAPP1. Mol Biol Cell 2005; 16: 1282-95.
36. Wang PY, Weng J, Lee S, Anderson RG. The N terminus controls sterol binding while the C terminus regulates the scaffolding function of OSBP. J Biol Chem 2008; 283: 8034-45.
37. Pizzatti L, Sa LA, de Souza JM, Bisch PM, Abdelhay E. Altered protein profile in chronic myeloid leukemia chronic phase identified by a comparative proteomic study. Biochim Biophys Acta 2006; 1764: 929-42.
38. Ando T, Suguro M, Kobayashi T, Seto M, Honda H. Multiple fuzzy neural network system for outcome prediction and classification of 220 lymphoma patients on the basis of molecular profiling. Cancer Sci 2003; 94: 906-13.
39. Sander B, Flygare J, Porwit-Macdonald A et al. Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1. Int J Cancer 2005; 117: 418-30.
40. Chng WJ, Schop RF, Price-Troska T et al. Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma. Blood 2006; 108: 2755-63.
41. Ek S, Andreasson U, Hober S et al. From gene expression analysis to tissue microarrays: A rational approach to identify therapeutic and diagnostic targets in lymphoid malignancies. Mol Cell Proteomics 2006; 5: 1072-81.
42. Sperger JM, Chen X, Draper JS et al. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci USA 2003; 100: 13 350-5.
43. Gashaw I, Grummer R, Klein-Hitpass L et al. Gene signatures of testicular seminoma with emphasis on expression of ets variant gene 4. Cell Mol Life Sci 2005; 62: 2359-68.
44. Juric D, Sale S, Hromas RA et al. Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures. Proc Natl Acad Sci USA 2005; 102: 17 763-8.
45. Loilome W, Yongvanit P, Wongkham C et al. Altered gene expression in Opisthorchis viverrini -associated cholangiocarcinoma in hamster model. Mol Carcinog 2006; 45: 279-87.